Maryam Saeidifar

Dr. Maryam Saeidifar

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2021 in Polymers
Verified
Journal Article
Open access
PDF file
ZNZohreh Mousavi Nejad
Zohreh Mousavi Nejad
AZAli Zamanian
Ali Zamanian
MSMaryam Saeidifar
Maryam Saeidifar
Hamid VanaeiHamid Vanaei
Hamid Vanaei
MAMehdi Salar Amoli
Mehdi Salar Amoli
In this study, two structurally different scaffolds, a polycaprolactone (PCL)/45S5 Bioglass (BG) composite and PCL/hyaluronic acid (HyA) were fabricated by 3D printing technology and were evaluated for the regeneration of dentin and pulp tissues, respectively. Their physicochemical characterization was performed by field emission scanning electron microscopy (FESEM) equipped with energy dispersive spectroscopy (EDS), Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), atomic force microscopy (AFM), contact angle, and compressive strength tests. The results indicated that the presence of BG in the PCL/BG scaffolds promoted the mechanical properties, surface roughness, and bioactivity. Besides, a surface treatment of the PCL scaffold with HyA considerably increased the hydrophilicity of the scaffolds which led to an enhancement in cell adhesion. Furthermore, the gene expression results showed a significant increase in expression of odontogenic markers, e.g., dentin sialophosphoprotein (DSPP), osteocalcin (OCN), and dentin matrix protein 1 (DMP-1) in the presence of both PCL/BG and PCL/HyA scaffolds. Moreover, to examine the feasibility of the idea for pulp-dentin complex regeneration, a bilayer PCL/BG-PCL/HyA scaffold was successfully fabricated and characterized by FESEM. Based on these results, it can be concluded that PCL/BG and PCL/HyA scaffolds have great potential for promoting hDPSC adhesion and odontogenic differentiation.

19 December 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
MSMona Shahlaei
Mona Shahlaei
SAShaahin Mohammadzadeh Asl
Shaahin Mohammadzadeh Asl
ADAtefe Derakhshani
Atefe Derakhshani
LKLeonie Kurek
Leonie Kurek
JKJohannes Karges
Johannes Karges
ASAli Akbar Saboury
Ali Akbar Saboury

3 January 2020 in IET Nanobiotechnology
Verified
Journal Article
Open access
PDF file
VZVahid Ziaaddini
Vahid Ziaaddini
MSMaryam Saeidifar
Maryam Saeidifar
MEMahboubeh Eslami‐Moghadam
Mahboubeh Eslami‐Moghadam
MSMandana Saberi
Mandana Saberi
MMMasoud Mozafari
Masoud Mozafari
To sustained release of an anticancer drug, oxaliplatin (OX), a non‐toxic and biocompatible nanocarrier based on bovine serum albumin (BSA) were synthesised by desolvation method and characterised using Fourier‐transform infrared (FTIR) spectroscopy, field emission scanning electron microscopy (FESEM), atomic force microscopy (AFM) and dynamic light scattering. The results showed that the BSA nanoparticles (BSANPs) with a mean magnitude of 187.9 ± 1.2 nm have spherical morphology with a smooth surface and a uniform distribution. Furthermore, OX was loaded onto the BSANPs and the loading was confirmed by FTIR, AFM and FESEM techniques. The percentage of encapsulation efficiency and drug loading were determined by absorption spectroscopy (UV–vis). The drug release studies showed that release of OX from BSANPs exhibited slower release rate. However, the release kinetics followed the first‐order kinetic for both of them with the non‐Fickian release behaviour. The electrochemical analysis showed stability of OX loaded onto the BSANPs (OX@BSANPs) and confirmed the diffusion mechanism. Furthermore, the results of MTT assay revealed increasing of normal cell viability and cancer cell death in the OX@BSANPs compared to only OX. It was shown that the BSANPs could be safely used as a biocompatible nanocarrier for the sustained release of OX.

1 April 2017 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
ZSZ. Sohrabijam
Z. Sohrabijam
MSMaryam Saeidifar
Maryam Saeidifar
AZA. Zamanian
A. Zamanian

9 July 2019 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
NKNassim Fattahian Kalhor
Nassim Fattahian Kalhor
MSMaryam Saeidifar
Maryam Saeidifar
HRHassan Ramshini
Hassan Ramshini
ASAli Akbar Saboury
Ali Akbar Saboury
The interaction ability of bovine serum albumin (BSA) with 2,6-divanillylidenecyclohexanone (DVH) as a stable curcumin derivative was investigated using fluorescence and circular dichroism (CD) spectroscopy techniques under simulative physiological conditions (pH = 7.2). Following the obtained results of binding studies, bovine serum albumin nanoparticles (BSANPs) were synthesized and characterized using Fourier transform infrared spectroscopy (FT-IR), filed emission scanning electron microscopy (FE-SEM), atomic force microscope (AFM) and dynamic light scattering (DLS). The stable BSANPs showed a spherical shape with a diameter of 149.14 ± 46.69 nm and the formulation of BSA had no change during the fabrication process. DVH was loaded on BSANPs (DVH@BSANPs) and the release studies showed sustained release of DVH from BSANPs. The validation of DVH@BSANPs system confirmed that the Fickian release mechanism of DVH followed on Korsmeyer–Pepas model. The in vitro studies on HFFF2 and MDA-MB-231 were investigated using MTT assay, DAPI and annexinV/PI staining that showed biocompatible BSANPs reduced the cytotoxicity of DVH in normal cell lines significantly, and antitumor activity of DVH was increased when it was loaded onto BSANPs without necrosis. These results suggest that DVH@BSANPs are a novel biocompatible sustained release system for effective therapeutic approach. Communicated by Ramaswamy H. Sarma

27 March 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
AHAmeneh Heidari
Ameneh Heidari
HMHassan Mansouri-Torshizi
Hassan Mansouri-Torshizi
MSMaryam Saeidifar
Maryam Saeidifar
EDEffat Dehghanian
Effat Dehghanian
KAKhatereh Abdi
Khatereh Abdi
HDHojat Samareh Delarami
Hojat Samareh Delarami